Association analysis of the dopamine transporter (DAT1)-67A/T polymorphism in bipolar disorder

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 135 B, Issue 1, 2005, Pages 47-49

  Keikhaee, M R ^a   Fadai, F ^b   Sargolzaee, M R ^c   Javanbakht, A ^c   Najmabadi, H ^a   Ohadi, M ^a  

^a UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

^b Razi Psychiatric Center   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Association; Bipolar; DAT1; Polymorphism

Indexed keywords

ADENINE; DOPAMINE TRANSPORTER; THYMINE DERIVATIVE;

ADULT; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DAT1 GENE; DOPAMINERGIC SYSTEM; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA;

ALLELES; BIPOLAR DISORDER; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS);

IRANIA;

EID: 17744396470     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30174     Document Type: Article

References (26)

1. American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders, 4th edition, text revision. (DSM-IV-TR). Washington, DC: APA.
2. Badner JA, Gershon ES. 2002. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 7:405-411.
3. Bailer U, Leisch F, Meszaros K, Lenzinger E, Willinger U, Strobl R, Heiden A, Gebhardt C, Doge E, Fuchs K, Sieghart W, Kasper S, Hornik K, Aschauer HN. 2002. Genome scan for susceptibility loci for schizophrenia and bipolar disorder. Biol Psychiatry 52:40-52.
4. Bannon MJ, Granneman JG, Kapator G. 1995. The dopamine transporter. Potential involvement in neuropsychiatric disorders. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: The fourth generation of progress. New York: Raven Press, pp 179-188.
5. Bannon MJ, Michelhaugh SK, Wang J, Sacchetti P. 2001. The human dopamine transporter gene: Gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders. Eur Neuropsychopharmacol 11:449-455.
6. Bramon E, Sham PC. 2001. The common genetic liability between schizophrenia and bipolar disorder: A review. Curr Psychiatry Rep 4: 332-337.
7. Cordeiro ML, Gundersen CB, Umbach JA. 2004. Convergent effects of lithium and valproate on the expression of proteins associated with large dense core vesicles in NGF-differentiated PC12 cells. Neuropsychopharmacology 1:39-44.
8. Detera-Wadleigh SD, Badner JA, Berrettini WH, Yoshikawa T, Goldin LR, Turner G, Rollins DY, Moses T, Sanders AR, Karkera JD, Esterling LE, Zeng J, Ferraro TN, Guroff JJ, Kazuba D, Maxwell ME, Nurnberger JI Jr, Gershon ES. 1999. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18q11.2. Proc Natl Acad Sci USA 96:5604-5609.
9. Donovan DM, Vanderbergh DJ, Perry MP, Bird GS, Ingersoll R, Nanthakumar E, Uhl GR. 1995. Human and mouse dopamine transporter genes: Conservation of 5′-flanking sequence elements and gene structures. Brain Res Mol Brain Res 30:327-335.
10. Greenwood TA, Kelsoe JE. 2003. Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. Genomics 82:511-519.
11. Greenwood T, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA, Kelsoe JR. 2001. Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am J Med Genet Neuropsychiatr Genet 105:145-151.
12. Greenwood T, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA, Shaw SH, Kelsoe JR. 2002. Segmental linkage disequilibrium between the dopamine transporter and bipolar disorder. Mol Psychiatry 7:165-173.
13. Grunhage F, Schulze TG, Muller DJ, Lanczik M, Franzek E, Albus M, Borrmannn-Hassenbach M, Knapp M, Cichon S, Maier W, Rietschel M, Propping P, Nothen MM. 2000. Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1). Mol Psychiatry 5:275-282.
14. Khodayari N, Garshasbi M, Fadai F, Rahimi A, Hafizi L, Ebrahimi A, Najmabadi H, Ohadi M. 2004. Association of the dopamine transporter gene (DAT1) core promoter polymorphism -67T variant with schizophrenia. Am J Med Genet 129B:10-12.
15. Knable MB, Barci BM, Webster MJ, Meador-Woodruff J, Torrey EF. 2004. Molecular abnormalities of the hippocampus in severe psychiatric illness: Postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 6:609-620, 544.
16. Lyseng-Williamson KA, Perry CM. 2004. Aripiprazole: In acute mania associated with bipolar I disorder. CNS Drugs 18:367-376; discussion 377-378.
17. Muglia P, Petronis A, Mundo E, Lander S, Gate T, Kennedy JL. 2002. Dopamine D4 receptor and tyrosine hydroxylase genes in bipolar disorder: Evidence for a role of DRD4. Mol Psychiatry 7:860-866.
18. Pantazopoulos H, Stone D, Walsh J, Benes FM. 2004. Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics. Synapse 54:147.
19. Ralph-Williams RJ, Paulus MP, Zhuang X, Hen R, Geyer MA. 2003. Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system. Biol Psychiatry 53:352-359.
20. Rubie C, Schmidt F, Knapp M, Sprandel J, Wiegand C, Meyer J, Jungkunz G, Riederer P, Stober G. 2001. The human dopamine transporter gene: The 5′-flanking region reveals five diallelic polymorphic sites in a Caucasian population sample. Neurosci Lett 297:125-128.
21. Sacchetti P, Brownschidle LA, Granneman JG, Bannon MJ. 1999. Characterization of the 5′-flanking region of the human dopamine transporter gene. Mol Brain Res 74:167-174.
22. Segurado R, Detera-Wadleigh SD, Levinson DF, Lewis CM, Gill M, Nurnberger JI Jr, et al. 2003. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet 73:49-62.
23. Tsuang MT, Taylor L, Faraone SV. 2004. An overview of the genetics of psychotic mood disorders. J Psychiatr Res 38:3-15.
24. Vandenbergh DJ, Thompson MD, Cook EH, Bendahhou E, Nguyen T, Krasowski MD, Zarrabian D, Comings D, Sellers EM, Tyndale RF, George SR, O'Dowd BF, Uhl GR. 2000. Human dopamine transporter gene: Coding region conservation among normal, Tourette's disorder, alcohol dependence, and attention-deficit hyperactivity disorder populations. Mol Psychiatry 5:283-292.
25. Waldman ID, Robinson BF, Feigon SA. 1997. Linkage disequilibrium between the dopamine transporter gene (DAT1) and bipolar disorder: Extending the transmission disequilibrium test (TDT) to examine genetic heterogeneity. Genet Epidemiol 14:699-704.
26. Young RC, Biggs JT, Ziegler VE, Meyer DA. 1978. A rating scale for mania: Reliability, validity, and sensitivity. Br J Psychiatry 133:429-435.